SG64894A1 - Method of treating hepatitis c in non-responders to interferon treatment - Google Patents
Method of treating hepatitis c in non-responders to interferon treatmentInfo
- Publication number
- SG64894A1 SG64894A1 SG1996005604A SG1996005604A SG64894A1 SG 64894 A1 SG64894 A1 SG 64894A1 SG 1996005604 A SG1996005604 A SG 1996005604A SG 1996005604 A SG1996005604 A SG 1996005604A SG 64894 A1 SG64894 A1 SG 64894A1
- Authority
- SG
- Singapore
- Prior art keywords
- responders
- treating hepatitis
- interferon treatment
- hepatitis
- potentiating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/027,500 US6001799A (en) | 1991-09-13 | 1993-03-05 | Method of treating hepatitis C in non-responders to interferon treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG64894A1 true SG64894A1 (en) | 1999-05-25 |
Family
ID=21838079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996005604A SG64894A1 (en) | 1993-03-05 | 1994-03-03 | Method of treating hepatitis c in non-responders to interferon treatment |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0687181B1 (ko) |
| JP (1) | JPH06279309A (ko) |
| KR (1) | KR100306024B1 (ko) |
| CN (1) | CN1072961C (ko) |
| AT (1) | ATE204760T1 (ko) |
| AU (1) | AU683248B2 (ko) |
| CA (1) | CA2157479C (ko) |
| DE (1) | DE69428112T2 (ko) |
| DK (1) | DK0687181T3 (ko) |
| ES (1) | ES2162862T3 (ko) |
| FI (1) | FI954127A0 (ko) |
| GR (1) | GR3037021T3 (ko) |
| MY (1) | MY121198A (ko) |
| NO (1) | NO320877B1 (ko) |
| PT (1) | PT687181E (ko) |
| SG (1) | SG64894A1 (ko) |
| WO (1) | WO1994020131A1 (ko) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7473096A (en) | 1995-11-02 | 1997-05-22 | Schering Corporation | Continuous low-dose cytokine infusion therapy |
| US7208167B2 (en) | 2000-08-07 | 2007-04-24 | Sciclone Pharmaceuticals, Inc. | Treatment of hepatitis C with thymosin and peptide combination therapy |
| ES2267810T3 (es) * | 2000-08-07 | 2007-03-16 | Sciclone Pharmaceuticals, Inc. | Tratamiento de la hepatitis c con timosina y peginterferon. |
| US8207294B2 (en) | 2003-03-28 | 2012-06-26 | Sciclone Pharmaceuticals, Inc. | Treatment of Aspergillus infections with alpha thymosin peptides |
| WO2007128647A1 (en) * | 2006-05-02 | 2007-11-15 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | USE OF THYMOSIN α1, ALONE OR IN COMBINATION WITH PTX3 OR GANCICLOVIR, FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION |
| WO2010122538A1 (en) * | 2009-04-24 | 2010-10-28 | Santaris Pharma A/S | Pharmaceutical compositions for treatment of hcv patients that are non-responders to interferon |
| CN102458470B (zh) | 2009-05-08 | 2016-01-20 | 赛生制药有限公司 | 作为疫苗增强剂的α胸腺素肽 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1216056B (it) * | 1988-03-11 | 1990-02-22 | Sclavo Spa | Composizioni farmaceutiche contenenti timosina alfa 1. |
| TW224053B (ko) * | 1991-09-13 | 1994-05-21 | Paul B Chretien |
-
1993
- 1993-09-27 CN CN93119345A patent/CN1072961C/zh not_active Expired - Lifetime
- 1993-12-27 JP JP5331601A patent/JPH06279309A/ja active Pending
-
1994
- 1994-02-18 MY MYPI94000381A patent/MY121198A/en unknown
- 1994-03-03 AT AT94910226T patent/ATE204760T1/de active
- 1994-03-03 SG SG1996005604A patent/SG64894A1/en unknown
- 1994-03-03 DE DE69428112T patent/DE69428112T2/de not_active Expired - Lifetime
- 1994-03-03 ES ES94910226T patent/ES2162862T3/es not_active Expired - Lifetime
- 1994-03-03 DK DK94910226T patent/DK0687181T3/da active
- 1994-03-03 WO PCT/US1994/002320 patent/WO1994020131A1/en active IP Right Grant
- 1994-03-03 CA CA002157479A patent/CA2157479C/en not_active Expired - Fee Related
- 1994-03-03 KR KR1019950703297A patent/KR100306024B1/ko not_active IP Right Cessation
- 1994-03-03 EP EP94910226A patent/EP0687181B1/en not_active Expired - Lifetime
- 1994-03-03 PT PT94910226T patent/PT687181E/pt unknown
- 1994-03-03 AU AU62759/94A patent/AU683248B2/en not_active Ceased
-
1995
- 1995-09-04 NO NO19953473A patent/NO320877B1/no not_active IP Right Cessation
- 1995-09-04 FI FI954127A patent/FI954127A0/fi unknown
-
2001
- 2001-10-25 GR GR20010401892T patent/GR3037021T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1072961C (zh) | 2001-10-17 |
| EP0687181B1 (en) | 2001-08-29 |
| KR100306024B1 (ko) | 2001-11-30 |
| PT687181E (pt) | 2002-01-30 |
| KR960700741A (ko) | 1996-02-24 |
| AU683248B2 (en) | 1997-11-06 |
| WO1994020131A1 (en) | 1994-09-15 |
| CA2157479C (en) | 2000-08-08 |
| ATE204760T1 (de) | 2001-09-15 |
| FI954127A (fi) | 1995-09-04 |
| FI954127A0 (fi) | 1995-09-04 |
| NO320877B1 (no) | 2006-02-06 |
| DK0687181T3 (da) | 2001-10-01 |
| GR3037021T3 (en) | 2002-01-31 |
| MY121198A (en) | 2006-01-28 |
| JPH06279309A (ja) | 1994-10-04 |
| CA2157479A1 (en) | 1994-09-15 |
| CN1092322A (zh) | 1994-09-21 |
| NO953473L (no) | 1995-09-04 |
| EP0687181A1 (en) | 1995-12-20 |
| ES2162862T3 (es) | 2002-01-16 |
| DE69428112T2 (de) | 2002-03-21 |
| AU6275994A (en) | 1994-09-26 |
| DE69428112D1 (de) | 2001-10-04 |
| NO953473D0 (no) | 1995-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ309217A (en) | Ribavirin and interferon alpha for the treatment of hepatitis C | |
| EA199800674A1 (ru) | Способ повторного лечения больных гепатитом с | |
| ES2103966T3 (es) | Uso de una timosina en el tratamiento de hepatitis c. | |
| MY133891A (en) | Polyethylene glycol modified interferon therapy | |
| RO115700B1 (ro) | Metodă de tratament cu interferon | |
| SG64894A1 (en) | Method of treating hepatitis c in non-responders to interferon treatment | |
| EP0616535A4 (en) | PROCESS FOR THE TREATMENT OF VIRAL INFECTIONS. | |
| ES2036526T3 (es) | Composiciones de interferon. | |
| BR9913951A (pt) | Tratamento de infecção de hepatite b com timosina alfa 1 em combinação com lamivudina e flamciclovir | |
| PH31116A (en) | Methods for the treatment of infection caused by hepatitis B virus (hbv). | |
| CY1106388T1 (el) | Θepαπεια ηπατιτιδας c με θυμοσινη, ιντepφepονη και ριβαβιρινη | |
| Carreno et al. | Other approaches to the treatment of chronic viral hepatitis | |
| RU98109203A (ru) | Способ лечения вирусного гепатита b у детей | |
| HK1056117A1 (en) | Treatment of hepatitis C with thymosin and pegylated interferon | |
| EP1143981A4 (en) | TREATMENT AND PREVENTION OF HIV AND OTHER VIRUS INFECTIONS | |
| BR112022006913A2 (pt) | Métodos para tratar infecções virais de hepatite delta | |
| ECSP982492A (es) | Terapia de interferones polietilenglicol, modificados |